Sten Madsbad

Sten Madsbad

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
11 - 20 out of 475Page size: 10
Sort by: Title
  1. Published

    Updates in weight loss surgery and gastrointestinal peptides

    Svane, M. S., Bojsen-Møller, K. N., Madsbad, Sten & Holst, Jens Juul, Feb 2015, In: Current Opinion in Endocrinology, Diabetes and Obesity. 22, 1, p. 21-8 8 p.

    Research output: Contribution to journal › Review › Research › peer-review

  2. Published

    Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report

    Knop, Filip Krag, Lund, Asger Bach, Madsbad, Sten, Holst, Jens Juul, Krarup, T. & Vilsbøll, T., 2014, In: BMC Research Notes. 7, p. 1-6 6 p., 326.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Under-reporting of adverse effects of tesofensine

    Astrup, A., Madsbad, Sten, Breum, Leif, Jensen, T. J., Kroustrup, J. P. & Larsen, T. M., 2013, In: Lancet. 382, 9887, p. 127 1 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  4. Published

    Udfordringer for perioperativ glykæmisk kontrol hos patienter med diabetes

    Madsbad, Sten, Wiberg, M., Issa, L. M., Schmidt, S. & Kehlet, Henrik, 17 Oct 2022, In: Ugeskrift for Laeger. 184, 42, 9 p., V05220321.

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    Type 2-diabetes--et sammenhængende sundhedsvæsen efterlyses

    Madsbad, Sten, 2012, In: Ugeskrift for Laeger. 174, 37, p. 2131

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Type 2 diabetes: which drug as add-on to metformin?

    Madsbad, Sten, 2012, In: Lancet. 379, 9833, p. 2222-3 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study

    Frandsen, C. S., Dejgaard, T. F., Holst, Jens Juul, Andersen, H. U., Thorsteinsson, B. & Madsbad, Sten, Dec 2015, In: Diabetes Care. 38, 12, p. 2250-7 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose- and non-glucose-induced insulin secretion in patients with type 2 diabetes mellitus

    Aaboe, K., Knop, Filip Krag, Vilsbøll, Tina, Deacon, Carolyn F., Holst, Jens Juul, Madsbad, Sten & Krarup, T., 2010, In: Diabetes, Obesity and Metabolism. 12, 4, p. 323-333 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial

    Aaboe, K., Knop, F. K., Vilsbøll, Tina, Deacon, Carolyn F., Holst, Jens Juul, Madsbad, Sten & Krarup, T., 2009, In: Diabetologia. p. 748

    Research output: Contribution to journal › Conference abstract in journal › Research

  10. Published

    Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy

    Haugaard, S. B., Andersen, Ove, Pedersen, S., Dela, Flemming, Fenger, M., Richelsen, B., Madsbad, Sten, Iversen, J. & Pedersen, E. S., 2006, In: Metabolism - Clinical and Experimental. 55, 2, p. 175-82 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...48 Next

ID: 10877